Mediolateral stability index as a biomarker for Parkinson's disease progression: A graph connectivity based approach

被引:0
|
作者
Mazumder, Oishee [1 ]
Gavas, Rahul [1 ]
Sinha, Aniruddha [1 ]
机构
[1] Tata Consultancy Serv, TCS Res & Innovat, Kolkata, India
关键词
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This paper presents a novel metric to serve as a bio-marker for understanding and detecting progression of Parkinson's disease (PD). Proposed metric, termed as 'Mediolateral Stability (MLS) index' has been derived from processing insole gait data using graph connectivity analysis. The proposed metric focuses on variability of mediolateral pressure in foot during gait progression. Vertical Ground Reaction Force (VGRF) and stride time information derived from a wearable insole for PD subjects as well as healthy controls are processed to create a connectivity graph. The insole contains eight pressure sensitive sensors for each foot and these sensors serve as the nodes of the connectivity graph. The proposed MLS index shows significant difference (p <0.05) in between control and PD groups and also in between progressive stages of PD, such as mild and moderate PD groups with p <0.05. Proposed graph connectivity based feature can act as a bio marker to correctly classify PD, identify early onset of PD and trace changes due to disease progression and can also provide information about dynamic pressure distribution during gait.
引用
收藏
页码:5063 / 5067
页数:5
相关论文
共 50 条
  • [1] Gustatory Connectivity in Parkinson's Disease Progression
    Chatterjee, H.
    Elumalai, G.
    Sewram, N.
    Osakwe, N.
    MOVEMENT DISORDERS, 2019, 34 : S629 - S631
  • [2] Qalb as a biomarker of Parkinson's disease progression
    Boika, A.
    Ponomarev, V.
    Mazurenka, K.
    Chyzhyk, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 625 - 625
  • [3] Blood transcriptomic biomarker of disease progression in Parkinson's Disease
    Lee, R.
    Seok, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S736 - S736
  • [4] Gustatory neural structural connectivity in Parkinson's disease progression
    Chatterjee, H.
    Elumalai, G.
    Maiti, P.
    Osakwe, N.
    Sewram, N.
    Vinodhanad, G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [5] A Milestone-based approach to monitoring disease progression in Parkinson's disease
    Brumm, M.
    Siderowf, A.
    Simuni, T.
    Caspell-Garcia, C.
    Chahine, L.
    Foroud, T.
    Arnedo, V.
    Reimer, A.
    Tanner, C.
    Poston, K.
    Weintraub, D.
    Hutten, S.
    Kieburtz, K.
    Marek, K.
    Coffey, C.
    MOVEMENT DISORDERS, 2021, 36 : S163 - S163
  • [6] Toward preventing Parkinson's disease A glycoprotein is a possible biomarker of pathogenic progression for Parkinson's disease
    Mollenhauer, Brit
    von Arnim, Christine A. F.
    SCIENCE, 2022, 377 (6608) : 818 - 819
  • [8] Imaging of dopamine transporters: Biomarker for progression in Parkinson's disease
    Innis, RB
    Seibyl, J
    Marek, K
    CNS DRUG REVIEWS, 2000, 6 : 33 - 33
  • [9] Potential role of retina as a biomarker for progression of Parkinson's disease
    Tian, Tian
    Zhu, Xiao-Hua
    Liu, Yun-Hai
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (04) : 433 - 438
  • [10] Parkinson's Progression Markers Initiative (PPMI): Investigating Biomarker Driven Parkinson's disease (PD) Progression
    McMahon, B.
    Siderowf, A.
    Simuni, T.
    Tanner, C.
    Mollenhauer, B.
    Coffey, C.
    Galasko, D.
    Poston, K.
    Chahine, L.
    Dobkin, R.
    Foroud, T.
    Kieburtz, K.
    Weintraub, D.
    Merchant, K.
    Frasier, M.
    Sherer, T.
    Chowdury, S.
    Brown, E.
    Alcalay, R.
    Videnovic, A.
    Fabrizio, K.
    Flagg, E.
    Stanley, C.
    Marek, K.
    MOVEMENT DISORDERS, 2024, 39 : S331 - S331